Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Unresectable Colorectal Cancer × magrolimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unresectable Colorectal Cancer 1 Pancreatic Neoplasms 1 Hodgkin Disease 1

Interventions

magrolimab 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Fluorouracil 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540261 2024-09-19

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Ono Pharmaceutical Co. Ltd

Phase 1 Active not recruiting

Gastrointestinal

Unresectable Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡